Phaseline

Companies › Corza Medical

Corza Medical: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 3; Other; next expected readout Dec 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
Fibrinogen, Human
Fibrinogen exogenous protein
FGA, FGB, FGGPhase 3HemorrhageDec 2026

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06664775Fibrinogen, HumanPhase 3HemorrhageOtherDec 2026

Targets

FGA (1) FGB (1) FGG (1)

Companies with the same targets

CSL Behring

Companies built like this

Rebel Medicine ITB-Med AgelessRx Huons Biopharma Neuren Pharmaceuticals

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.